1. OAR@UM
  2. Faculty of Medicine and Surgery
  3. Department of Pharmacy
  4. Scholarly Works - FacM&SPha
Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/51025
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2020-01-29T11:17:02Z-
dc.date.available2020-01-29T11:17:02Z-
dc.date.issued2018-11-
dc.identifier.citationNamulindwa, C. M., Vella Szijj, J., & Serracino-Inglott, A. (2018, November). Availability of antiretroviral drugs and patient adherence: a comparison between Malta and Norway. Poster session presented at the X Malta Medical School Conference, St Julian's, Malta.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/51025-
dc.description.abstractA poster presentation regarding the availability of antiretroviral drugs and patient adherence: a comparison between Malta and Norway. Introduction: Newer antiretroviral drugs (ARVs) are recommended as first line agents because they are more tolerable in terms of adverse events, and achieve faster viral suppression. Discontinuation of antiretroviral treatment (ART) due to adverse events was shown to be 4% (16/414) in patients on newer ARVs compared to 14% (58/419) in patients on older ARVs. Malta and Norway have the same prevalence of HIV (0.1%) but different incidence rates. Malta reported an HIV incidence rate of 14.5 per 100,000 population in 2016 compared to 4.2 per 100,000 population in Norway. Aims: ▫ To compare the availability of ARVs in Malta and Norway. ▫ To determine factors associated with availability of ARVs and patient adherence in Malta and Norway.en_GB
dc.language.isoenen_GB
dc.publisherUniversity of Malta. Department of Pharmacyen_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectAntiretroviral agents -- Treatment -- Maltaen_GB
dc.subjectAntiretroviral agents -- Treatment -- Norwayen_GB
dc.subjectPatient compliance -- Maltaen_GB
dc.subjectPatient compliance -- Norwayen_GB
dc.subjectPharmacists -- Interviewsen_GB
dc.titleAvailability of antiretroviral drugs and patient adherence : a comparison between Malta and Norwayen_GB
dc.typepresentationen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedN/Aen_GB
dc.contributor.creatorNamulindwa, Catherine M.-
dc.contributor.creatorVella Szijj, Janis-
dc.contributor.creatorSerracino-Inglott, Anthony-
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
Availability_of_antiretroviral_drugs_and_patient_adherence_a_comparison_between_Malta_and _Norway_2018.pdf382.58 kBAdobe PDFView/Open
Show simple item record Statistics


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.